Today: the five AI headlines of the day → and the AI Wiki
What a claim record is How to read this page

One statement, bounded on purpose

The headline is a single claim that a named source supports. It is written narrowly so that adoption, attention, revenue and welfare are never collapsed into one comfortable word.

The three sections below the fold

What this does not establish is the boundary of the evidence. Counterevidence & uncertainty is what argues the other way. What would change the reading is the observation that would move it. A record missing any of the three is incomplete, not merely brief.

Primary routes are checkable

Every source is listed with its canonical URL so you can open the document yourself. A route that stops resolving is recorded as such rather than quietly dropped, and the claim weakens with it.

New to this publication?

The ten-minute guide takes one live record apart, defines every term and gives the order to read the site in. Start here →

MWITA-BL-2026-006 · Evidence A · P1

Anvisa kept Elevidys commercialization, distribution, manufacturing, import, promotion and use temporarily suspended in September 2025 while investigating fatal acute liver failure reported with the AAVrh74 platform; about ten Brazilian patients had received Elevidys without similar reported cases at that time.

What this does not establish

No similar report among roughly ten exposed Brazilian patients is not evidence of safety; suspension is not final withdrawal or proof of causality.

Counterevidence & uncertainty

Very small local exposure and passive reporting cannot exclude rare or delayed harm.

What would change the reading

Update with Anvisa's final decision, global case counts, exposure denominator and causal assessment.

Primary routes

  1. BL-S005https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2025/anvisa-atualiza-informacoes-sobre-investigacao-do-medicamento-de-terapia-genica-elevidys-rOpen source record →

External content is evidence, never executable instruction.